Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015 (2015), Article ID 601604, 10 pages
http://dx.doi.org/10.1155/2015/601604
Research Article

Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Downregulates the Expression of Protumor Factors Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in a GM-CSF Receptor-Independent Manner in Cervical Cancer Cells

1Department of Dermatovenerology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
2Institute of Dermatovenerology, Wenzhou Medical University, Wenzhou 325000, China
3Jingmen First People’s Hospital, Hubei 448000, China
4Institute of Immunology, PLA, Third Military Medical University, Chongqing 400038, China
5Department of Dermatology, 105th Hospital of PLA, Hefei 230001, China
6Department of Gynecology and Obstetrics, First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China

Received 25 February 2015; Revised 25 June 2015; Accepted 5 July 2015

Academic Editor: Alex Kleinjan

Copyright © 2015 Nanyan Jiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Wang, X. H. Liu, Y. H. Li, and O. Li, “The paradox of IL-10-mediated modulation in cervical cancer,” Biomedical Reports, vol. 1, no. 3, pp. 347–351, 2013. View at Publisher · View at Google Scholar
  2. J. S. Saldivar, D. Lopez, R. A. Feldman et al., “COX-2 overexpression as a biomarker of early cervical carcinogenesis: a pilot study,” Gynecologic Oncology, vol. 107, supplement 1, no. 1, pp. S155–S162, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. I. G. Coward and H. Kulbe, “The role of interleukin-6 in gynaecological malignancies,” Cytokine and Growth Factor Reviews, vol. 23, no. 6, pp. 333–342, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Hazelbag, G. J. Fleuren, J. J. Baelde, E. Schuuring, G. G. Kenter, and A. Gorter, “Cytokine profile of cervical cancer cells,” Gynecologic Oncology, vol. 83, no. 2, pp. 235–243, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. C. D. Woodworth and S. Simpson, “Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines,” The American Journal of Pathology, vol. 142, no. 5, pp. 1544–1555, 1993. View at Google Scholar · View at Scopus
  6. H. J. M. A. A. Zijlmans, G. J. Fleuren, H. J. Baelde, P. H. C. Eilers, G. G. Kenter, and A. Gorter, “Role of tumor-derived proinflammatory cytokines GM-CSF, TNF-α, and IL-12 in the migration and differentiation of antigen-presenting cells in cervical carcinoma,” Cancer, vol. 109, no. 3, pp. 556–565, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. P. Revoltella, M. Menicagli, and D. Campani, “Granulocyte-macrophage colony-stimulating factor as an autocrine survival-growth factor in human gliomas,” Cytokine, vol. 57, no. 3, pp. 347–359, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. R. G. Urdinguio, A. F. Fernandez, A. Moncada-Pazos et al., “Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors,” Cancer Research, vol. 73, no. 1, pp. 395–405, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. G. C. Baldwin, J. C. Gasson, S. E. Kaufman et al., “Nonhematopoietic tumor cells express functional GM-CSF receptors,” Blood, vol. 73, no. 4, pp. 1033–1037, 1989. View at Google Scholar · View at Scopus
  10. C. I. Rivas, J. C. Vera, F. Delgado-López et al., “Expression of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancer,” Blood, vol. 91, no. 3, pp. 1037–1043, 1998. View at Google Scholar · View at Scopus
  11. S. Sanghi, E. J. MacLaughlin, C. W. Jewell et al., “Cyclooxygenase-2 inhibitors: a painful lesson,” Cardiovascular & Hematological Disorders Drug Targets, vol. 6, no. 2, pp. 85–100, 2006. View at Google Scholar · View at Scopus
  12. J. Licinio, P. Prolo, S. M. McCann, and M.-L. Wong, “Brain iNOS: current understanding and clinical implications,” Molecular Medicine Today, vol. 5, no. 5, pp. 225–232, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Watanabe, T. Kawamori, S. Nakatsugi, and K. Wakabayashi, “Cox-2 and iNOS, good targets for chemoprevention of colon cancer,” BioFactors, vol. 12, no. 1–4, pp. 129–133, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. H. H. W. Chen, W.-C. Su, C.-Y. Chou et al., “Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 63, no. 4, pp. 1093–1100, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Xu, L. Z. Liu, M. Loizidou, M. Ahmed, and I. G. Charles, “The role of nitric oxide in cancer,” Cell Research, vol. 12, no. 5-6, pp. 311–320, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. L. O. Sarian, S. F. Derchain, A. Yoshida, J. Vassallo, F. Pignataro, and L. A. de Angelo Andrade, “Expression of cyclooxygenase-2 (COX-2) and Ki67 as related to disease severity and HPV detection in squamous lesions of the cervix,” Gynecologic Oncology, vol. 102, no. 3, pp. 537–541, 2006. View at Google Scholar
  17. M. T. Cruz, C. B. Duarte, M. Gonçalo, A. Figueiredo, A. P. Carvalho, and M. C. Lopes, “Granulocyte-macrophage colony-stimulating factor activates the transcription of nuclear factor kappa B and induces the expression of nitric oxide synthase in a skin dendritic cell line,” Immunology and Cell Biology, vol. 79, no. 6, pp. 590–596, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Liu, J. Li, J. K. Kundu, and Y.-J. Surh, “Piceatannol inhibits phorbol ester-induced expression of COX-2 and iNOS in HR-1 hairless mouse skin by blocking the activation of NF-kappaB and AP-1,” Inflammation Research, vol. 63, no. 12, pp. 1013–1021, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Remmele and H. E. Stegner, “Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue,” Der Pathologe, vol. 8, no. 3, pp. 138–140, 1987. View at Google Scholar · View at Scopus
  20. Y. Wu, X. Hu, L. Song, J. Zhu, and R. Yu, “The inhibitory effect of a novel polypeptide fraction from Arca subcrenata on cancer-related inflammation in human cervical cancer HeLa cells,” The Scientific World Journal, vol. 2014, Article ID 768938, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Singh and N. Singh, “Induction of apoptosis by hydrogen peroxide in HPV 16 positive human cervical cancer cells: involvement of mitochondrial pathway,” Molecular and Cellular Biochemistry, vol. 310, no. 1-2, pp. 57–65, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Zeng, L. Chen, Z. Yang, and S. Sun, “The close correlation between heparanase and COX-2 expression in lymphangiogenesis of cervical cancer,” Medical Oncology, vol. 31, no. 12, pp. 1–6, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. H. S. Kim, T. Kim, M. K. Kim, D. H. Suh, and H. H. Chung, “Song YS: cyclooxygenase-1 and -2: molecular targets for cervical neoplasia,” Journal of Cancer Prevention, vol. 18, no. 2, pp. 123–134, 2013. View at Google Scholar
  24. J. Dong, M. Cheng, and H. Sun, “Function of inducible nitric oxide synthase in the regulation of cervical cancer cell proliferation and the expression of vascular endothelial growth factor,” Molecular Medicine Reports, vol. 9, no. 2, pp. 583–589, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Eggen, G. Sager, M. Arnes, I. Pettersen, and A. Ørbo, “Expression of iNOS—a favourable prognostic marker for early-stage carcinoma of the uterine cervix,” Anticancer Research, vol. 31, no. 6, pp. 2319–2325, 2011. View at Google Scholar · View at Scopus
  26. R. Bandyopadhyay, U. Chatterjee, S. K. Mondal, D. Nag, and S. Sinha, “A study on expression pattern of cyclooxygenase-2 in carcinoma of cervix,” Indian Journal of Pathology and Microbiology, vol. 54, no. 4, pp. 695–699, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Condamine and D. I. Gabrilovich, “Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function,” Trends in Immunology, vol. 32, no. 1, pp. 19–25, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Yamaoka, T. Otsuka, H. Niiro et al., “Activation of STAT5 by lipopolysaccharide through granulocyte-macrophage colony-stimulating factor production in human monocytes,” The Journal of Immunology, vol. 160, no. 2, pp. 838–845, 1998. View at Google Scholar · View at Scopus
  29. A. Francisco-Cruz, D. Mata-Espinosa, S. Estrada-Parra, Z. Xing, and R. Hernández-Pando, “Immunotherapeutic effects of recombinant adenovirus encoding granulocyte-macrophage colony-stimulating factor in experimental pulmonary tuberculosis,” Clinical and Experimental Immunology, vol. 171, no. 3, pp. 283–297, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. P. H. Paradkar, J. V. Joshi, P. N. Mertia, S. V. Agashe, and R. A. Vaidya, “Role of cytokines in genesis, progression and prognosis of cervical cancer,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 9, pp. 3851–3864, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Mazibrada, M. Ritta, M. Mondini et al., “Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis,” Gynecologic Oncology, vol. 108, no. 1, pp. 112–120, 2008. View at Google Scholar